Groowe Groowe / Newsroom / AZN
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AZN News

AstraZeneca PLC

Ibex Medical Analytics Establishes Biopharma Advisory Board to Advance AI-Powered Precision Diagnostics

businesswire.com
AZN

Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight

globenewswire.com
VNDA GRFS BHC RDHL MRK TEVA PFE SNY LLY ABBV AZN CRCT SPRO CRNX

The 28th China Beijing International High-Tech Expo Grand Opening Soon USA - English APAC - English India - English

prnewswire.com
AZN SNY

TRUQAP® (capivasertib) recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer

businesswire.com
AZN

Complement Inhibitors Market Outlook Remains Strong During the Forecast Period (2026–2036) with Increasing Adoption of C5 and C3 Targeted Drugs | DelveInsight

globenewswire.com
AZN IONS ARWR REGN SNY OMER

SKF commits to a sovereign AI future through strategic partnership with Sferical AI USA - English USA - English

prnewswire.com
ERIC AZN

Pinetree Therapeutics Announces Exercise of Option to License EGFR Degrader Program by AstraZeneca

prnewswire.com
AZN

IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight

globenewswire.com
NVS VRTX BIIB VTRS AZN IONS TAK ARWR WLDN

Alcoholism Treatment Market Report 2026: Revenue to Reach $36.85 Billion in 2026, Growing by $2.27 Billion YoY

globenewswire.com
ADIL ALKS AZN BCO CATX LLY GSK MRK PFE SNY TEVA

AstraZeneca results: Q1 2026

businesswire.com
AZN